Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 1

1(20.0%)

5Total

N/A(4)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07445802Not ApplicableNot Yet Recruiting

Medication Adherence in Severe Mental Illness: a Promotion Program

Role: collaborator

NCT07422090Recruiting

Preventing Suicide With Digital Phenotyping and Pharmacogenetics-Based Interventions

Role: collaborator

NCT06478160Not ApplicableRecruiting

Closed-blood Sampling Devices in the Adult Critically Ill Patient

Role: collaborator

NCT05523856Active Not Recruiting

New Treatment Modalities for Localized Prostate Cancer

Role: collaborator

NCT05933876Recruiting

The Impact of Radiotherapy on Oligometastatic Cancer

Role: collaborator

NCT03010280Not ApplicableCompleted

Effect of Immunonutrition on Inflamatory Markers After Bariatric Surgery

Role: collaborator

NCT02620358Not ApplicableCompleted

Two Opposite Strategies of Weaning From Mechanical Ventilation

Role: collaborator

NCT02602483Phase 1Completed

Exploratory Study To Assess the Efficacy and Safety of a Triple Combination for Acute Pain Treatment in Patients With Temporomandibular Joint Disorders (TMJD).

Role: collaborator

All 8 trials loaded